Medtronic (MDT)

MiniMed Group (NASDAQ:MMED) reported fiscal 2027 first-quarter revenue of $843 million, with organic revenue growth of 15.8%, as demand for its newer insulin-delivery and continuous glucose monitoring products supported growth in the United States and international markets. Chief Executive Officer

Medtronic (NYSE:MDT) reported fiscal 2027 first-quarter revenue of $9.8 billion and adjusted earnings per share of $1.45, as the medical-device maker cited broad-based demand, commercial execution and momentum in several growth platforms. Revenue increased 13.7% on both a reported and organic basis

Medtronic (NYSE: MDT) stock rose after beating Q1 estimates and raising its FY27 forecast on strong cardiovascular sales.

Shares of both advanced on their lifted full-year guidance.

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.58% to 52,876.43 while the NASDAQ dipped 1.40% to

With U.S. stock futures trading slightly lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Medtronic plc (NYSE:MDT) to release Q1 earnings on Sept. 1. Analysts expect $1.39/share, revenue of $9.54B. Dividend yield at 3.16%. Stock closed at $91.23 on Friday.

Medtronic plc (NYSE: MDT) will release Q1 earnings on Sept. 1. Analysts predict $1.39 EPS and $9.54B revenue. Stock fell 2.2% to $89.97 on Aug. 27.

The maternal health market is characterized by rapid technological advancements and increasing demand for improved prenatal and postnatal care solutions gl

On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.

Investors appear to be second-guessing the company's long-term growth prospects in light of its recent earnings numbers.

The space company is popular right now, but these other corporations look more attractive.

These stocks are leaders in their respective industries and have excellent financials to support their high-yielding dividend payments.

They are going through a rough patch, but it's too early to give up on them.

Intuitive Surgical is a leader in the surgical robotics space, with a large installed base and strong recurring revenues.

The medical device maker still has a bright future.

Pediatrix Medical Group (NYSE:MD) reported second-quarter 2026 adjusted EBITDA of $76 million and reaffirmed its full-year adjusted EBITDA outlook of $280 million to $300 million, as stronger revenue-cycle-management collections, payer mix and patient acuity offset lower patient-service volumes. Ch

These stocks pay between 3.4% and 6.1% in dividends.

Nvidia's physical AI business could be a juggernaut.

Medtronic could finally be on the cusp of a long-awaited turnaround.

In times of market turbulence, dividend-yielding stocks are popular for investors. Check out analyst ratings for high-yielding stocks and recent news on Bristol-Myers Squibb, GSK, and Medtronic PLC on Benzinga's Analyst Stock Ratings page.Investors turn to dividend-yielding stocks in turbulent markets. Check out analyst ratings and news for high-yielding stocks on Benzinga's Analyst Stock Ratings page.

According to a new report from Intel Market Research, the global Medical Video Laryngoscope Market was valued at USD 1,314 million in 2024 and is projected

At first glance, its numbers were impressive.